doi: 10.1037/neu0000425, 42
Relevant Research Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomised controlled trials Retatrutide for the treatment of obesity, obstructive sleep apnea, and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials Retatrutidea game changer in obesity pharmacotherapy Unleashing the power of retatrutide: a possible triumph over obesity Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomised phase 2a trial Retatrutide in type 2 diabetes mellitus and obesity: an overview
Still, this is not a good argument for the FDA to let unapproved peptide drugs be made widely available in the U.S
Glutathione with SOD: Focuses on cellular detox, immunity, skin health, and antioxidant recycling throughout the body
doi: 10.3390/ijms12107114 112 HoltcampW
References 1 AbrahemR.CaoR.RobinsonB.MunjalS.ChoT.ToK.AshleyD.et al